Naloxone: FDA recommends higher doses of nasal spray for opioid overdoses Opioid epidemicSubstance use disorderHealthcare Professional Apr 30 Written by Denise Kolakowski Learn more from the fda Denise Kolakowski Previous Previous FDA notification: Acella Pharmaceuticals issued voluntary recall of thyroid medication Next Next Poison Periodical Spring 2021-Quarterly Newsletter
Naloxone: FDA recommends higher doses of nasal spray for opioid overdoses Opioid epidemicSubstance use disorderHealthcare Professional Apr 30 Written by Denise Kolakowski Learn more from the fda Denise Kolakowski